Análisis Argos
PVH
PVHBarata · ojo al riesgo
PVH Corp. · Consumer Cyclical
US$ 75.23
precio al 2026-07-04
Valor justo Argos*
US$ 182–193
vs. su valor justo
57% por debajo
Score Argos
64/100
Barata · ojo al riesgo
LA RESPUESTA
El mercado la precia para que se encoja 26.1% al año — menos de lo que viene demostrando (0.5%). Un negocio de calidad castigado por expectativas pesimistas: por eso está entre las llamadas de Argos. Ojo: tiene señales de riesgo en sus números — es barata con asterisco.
Recompensas
✓Cotiza por debajo de su valor justo: el mercado le pide menos crecimiento del que viene demostrando.
Riesgos
!Balance frágil: la deuda pesa sobre el negocio.
!Crecimiento estancado o en baja.
VALOR4/6FUTURO1/6PASADO1/6SALUD2/6DIVIDENDO6/6
El Iris de calidad
VALOR4/6FUTURO1/6PASADO1/6SALUD2/6DIVIDENDO6/6
ValorCotiza por debajo de su valor justo
FuturoIngresos estancados o cayendo
PasadoHistorial débil
SaludBalance razonable
DividendoDevuelve capital al accionista
Score Argos64de 100Barata · ojo al riesgo
Ingresos▲3%
US$ 9 B
Margen operativo▼8%
7.3%
Flujo de caja libre▼7%
US$ 0.5 B
Deuda neta
US$ 3.6 B
Lo esencial, sin ruido
Cap. de mercadoUS$ 3.5B
P/E137.1x
EV/EBITDA7.6x
FCF yield15.5%
ROIC3.9%
Margen operativo7.3%
Crecim. ingresos+3.4%/año
Piotroski F5/9
Competidores

Los rivales, con el mismo ojo

El Iris de calidad de cada competidor, lado a lado. Tocá uno para ver su análisis.

Novedades

Noticias recientes

zacks.com · 3 jul
PVH (PVH) Down 3.8% Since Last Earnings Report: Can It Rebound?
PVH (PVH) reported earnings 30 days ago. What's next for the stock?
proactiveinvestors.com · 26 jun
First Graphene accelerates US expansion with MITO® acquisition - ICYMI
First Graphene Ltd (ASX:FGR, OTCQB:FGPHF, FRA:M11) earlier this week confirmed it had completed the acquisition of USA-based MITO® Material Solutions, with...
proactiveinvestors.com · 26 jun
Recce raises A$4M as it advances anti-infective trials and commercial licensing plans; another $4M to come in SPP
Recce Pharmaceuticals Ltd (ASX:RCE, OTC:RECEF) has raised A$4 million to support commercial licensing activity, clinical trials and regulatory-enabling work...
proactiveinvestors.com · 26 jun
Cyprium Metals strengthens Nifty restart team with CTO appointment
Cyprium Metals Ltd (ASX:CYM, OTCQB:CYPMF) has appointed experienced mining engineer and resources executive Christofer Catania as chief technical officer as...
proactiveinvestors.com · 25 jun
PVH downgraded by Bank of America on concerns over Europe exposure, recovery timeline
PVH Corp. (NYSE:PVH) was downgraded to 'Underperform' from 'Neutral' by Bank of America, which also lowered its price objective to $70 from $90, citing the apparel company's significant exposure to Europe, the Middle East and Africa (EMEA) and expectations that a recovery in the region could take longer than anticipated. Shares of PVH traded hands at $72 on Thursday afternoon, up about 7% so far this year.
proactiveinvestors.com · 25 jun
Varon Corp is building a next-generation beverage portfolio centered on hydration and wellness
Deep Dive - Varon Corp
proactiveinvestors.com · 25 jun
PVH downgraded by Bank of America on concerns over Europe exposure, recovery timeline
PVH Corp. (NYSE:PVH) was downgraded to 'Underperform' from 'Neutral' by Bank of America, which also lowered its price objective to $70 from $90, citing the...
benzinga.com · 25 jun
This PVH Analyst Turns Bearish; Here Are Top 3 Downgrades For Thursday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

* Valor justo Argos: estimación educativa del valor intrínseco según el propio flujo de caja de la empresa y su capacidad de crecimiento — no un precio objetivo ni una recomendación. Esto es información y educación, no asesoría de inversión. Rendimiento pasado no garantiza resultados futuros.